SATO VICKI L 4
4 · Allogene Therapeutics, Inc. · Filed Jun 23, 2025
Insider Transaction Report
Form 4
SATO VICKI L
Director
Transactions
- Award
Stock Option (Right to buy)
2025-06-18+144,400→ 144,400 totalExercise: $1.29Exp: 2035-06-18→ Common Stock (144,400 underlying)
Footnotes (1)
- [F1]Vesting in 12 equal monthly installments.